Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by husk16on Sep 04, 2013 4:04pm

218 Views

Post# 21718356

RE:RE:RE:JDSTOX nailed this one square on the head...sorry to say but it sums up the BB's

JD One last thing, when you post incorrect data, and you are corrected on it, and still dont change it. Then I say that what you write is a joke. In your last RVX post there is little to no factual information on it. You are posting your opinion on what you think will happen to RVX in the coming months. Opinions are fine. But get your FACTS right.

If I have posted any facts incorrectly please let me know. If I have posted incorrectly then I will correct them. Also, do you think there is a reason Fundamental6 wont help you with your blog?

Bullboard Posts

Morning Market Outlook for June 17, 2024